The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.
dc.contributor.author | Akbulut, Hakan | |
dc.contributor.author | Ocal, Muge | |
dc.contributor.author | Sonugur, Fatma Gizem | |
dc.contributor.author | Abgarmi, Samira Abdi | |
dc.contributor.author | Babahan, Cansu | |
dc.contributor.author | Akay, Busra | |
dc.contributor.author | Arslan, Ulku Yalcintas | |
dc.date.accessioned | 2024-02-23T14:29:10Z | |
dc.date.available | 2024-02-23T14:29:10Z | |
dc.date.issued | 2018 | |
dc.department | NEÜ | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.identifier.doi | 10.1200/JCO.2018.36.15_suppl.e15553 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.1200/JCO.2018.36.15_suppl.e15553 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/14584 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000442916005036 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Clinical Oncology | en_US |
dc.relation.ispartof | Journal Of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study. | en_US |
dc.type | Conference Object | en_US |